-
Symbol
-
SYRS on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.001 par value
-
Latest Disclosed Ownership
-
1.06M shares
-
Security Ownership
-
3.8%
Invus Public Equities, L.P. ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS)
2025-02-12 - Invus Public Equities, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.06M shares of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS).
This represents 3.8% percent ownership of the company.